GnRH Analogues in Cancer and Human Reproduction

1 The use of LHRH agonists in the treatment of uterine fibroids.- 2 Treatment of uterine fibroids with intra-nasal buserelin.- 3 Advances in the treatment of leiomyomata uteri with leuprolide.- 4 Relevance of an LHRH agonist to the treatment of uterine fibromyomas.- 5 Comparison of treatment of uterine leiomyomata with 3 different GnRH agonistic analogs.- 6 Sequential buserelin — medroxyprogesterone acetate treatment of uterine leiomyomata.- 7 Combined endoscopical and endocrinological treatment of uterine fibroids.- 8 Novel approaches to the treatment of advanced prostate cancer.- 9 Maximal androgen blockage in prostate cancer: today’s therapy of choice and 5-year clinical experience.- 10 Medical versus surgical orchiectomy in advanced prostatic cancer.- 11 Orchiectomy versus total androgen blockade. A Phase III EORTC 30853 study.- 12 Towards the best treatment for advanced prostatic cancer.- 13 Clinical studies of leuprolide depot formulation in metastatic prostatic cancer.- 14 Treatment of advanced prostatic carcinomas by an LH RH analogue with or without an anti-androgen.- 15 The use of GnRH analogues in ovarian cancer.- 16 GnRH analogues in the treatment of ovarian carcinoma.- 17 Partial tumor remission in recurrent low malignant stromal endometriosis following GnRH agonist treatment.- 18 Endocrine, pharmacokinetic and clinical effects of LHRH analogue treatment in patients with malignant and benign breast disease.- 19 LHRH analogs as adjuncts to somatostatin analogs in the treatment of pancreatic cancer.- 20 An FSH producing tumor: response to GnRH analogue.